薬王堂ホールディングス' first-half ordinary profit fell 9.4% year on year to ¥3.23 billion, coming in below its previous forecast for an increase in profit. The full-year progress rate was 59.1%, and estimates indicate that ordinary profit would increase to ¥2.24 billion in the second half based on the outlook for the remainder of the year.
薬王堂ホールディングス reported consolidated ordinary profit of ¥3.23 billion for the cumulative second quarter (March-August) of the fiscal year ending February 2027. This represented a 9.4% year-on-year decline and fell below its previous forecast for an increase in profit. Progress against the full-year plan was 59.1%, roughly in line with the five-year average of 61.6%.
For the latest three-month period, ordinary profit for June-August was ¥1.81 billion, down 10.1% year on year, while the operating margin on sales deteriorated to 4.1% from 4.5% in the same period last year.
Based on first-half results and the unchanged full-year plan, the outlook for the remainder of the fiscal year indicates that second-half ordinary profit is calculated to increase 18.3% year on year to ¥2.24 billion.